Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
接受 CAR-T 细胞疗法治疗的 COVID-19 患者预后随时间推移而改善：欧洲 COVID-19 多中心研究的最新进展（代表欧洲血液和骨髓移植学会 (EBMT) 传染病工作组 (IDWP) 和欧洲血液学协会 (EHA) 淋巴瘤组）
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-024-02336-1
Spanjaart, Anne Mea; Ljungman, Per; Tridello, Gloria; Schwartz, Juana; Martinez-Cibrián, Nuria; Barba, Pere; Kwon, Mi; Lopez-Corral, Lucia; Martinez-Lopez, Joaquin; Ferra, Christelle; Di Blasi, Roberta; Ghesquieres, Hervé; Mutsaers, Pim; Calkoen, Friso; Jak, Margot; van Doesum, Jaap; Vermaat, Joost S P; van der Poel, Marjolein; Maertens, Johan; Gambella, Massimiliano; Metafuni, Elisabetta; Ciceri, Fabio; Saccardi, Riccardo; Nicholson, Emma; Tholouli, Eleni; Matthew, Collin; Potter, Victoria; Bloor, Adrian; Besley, Caroline; Roddie, Claire; Wilson, Keith; Nagler, Arnon; Campos, Antonio; Petersen, Soeren Lykke; Folber, Frantisek; Bader, Peter; Finke, Jurgen; Kroger, Nicolaus; Knelange, Nina; de La Camara, Rafael; Kersten, Marie José; Mielke, Stephan
